Last update 01 Nov 2024

YK-029A

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mechanism
EGFR exon 20 inhibitors(EGFR exon 20 Mutation inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationSpecial Review Project (CN), Breakthrough Therapy (CN)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerPhase 3
CN
01 May 2023
EGFR ex20ins mutation in non-small cell lung cancerPhase 3
CN
01 Apr 2023
metastatic non-small cell lung cancerPhase 3
CN
01 Apr 2023
Advanced Lung Non-Small Cell CarcinomaPhase 2
CN
30 Mar 2018
EGFR T790M Mutation Positive Non-Small Cell Lung CarcinomaPhase 1
CN
12 Sep 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
38
(xpddmlvoai) = sicqrfwfsv xqhujhmlpp (tqhmuezycb, 68.7 - 94.0)
Positive
05 Apr 2024
Phase 1
108
(lnypwtbqmx) = wqbyvkcxvv iclufmrzti (jswddxzktj )
Positive
26 May 2023
(Treatment-naïve ex20ins)
(dcxyxoezkt) = zzpvpkecua jlklzqtrfj (ttbvzfbcmu, 74.87 - 99.05)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free